首页> 外文期刊>Natural product sciences >Analysis of the Components of Guibitang and Fermented Guibi-tang and their Ability to Inhibit Angiotensin-converting Enzyme
【24h】

Analysis of the Components of Guibitang and Fermented Guibi-tang and their Ability to Inhibit Angiotensin-converting Enzyme

机译:桂必当和发酵桂必汤的成分及其抑制血管紧张素转化酶的能力分析

获取原文
获取原文并翻译 | 示例
           

摘要

Guibi-tang is a traditional medicine used for the treatment of colds. We investigated the levels of several compounds in Guibi-tang before and after fermentation with Lactobacillus and tested their ability to inhibit angiotensin-converting enzyme. Six known compounds (decursin, decursinol angelate, nodakenin, liquiritin, formononetin, and 6-gingerol) and 2 unidentified compounds were detected in Guibi-tang (GB) and fermented Guibi-tang (FGB) by an established HPLC-DAD method. The levels of the 6 known compounds were decreased after fermentation. FGB showed more potent inhibition of angiotensin-converting enzyme activity than GB. In conclusion, fermentation with Lactobacillus affects the content of several compounds in GB and improves its angiotensin-converting enzyme inhibitory activity.
机译:归鼻汤是用于治疗感冒的传统药物。我们调查了乳杆菌发酵前后桂壁汤中几种化合物的水平,并测试了它们抑制血管紧张素转化酶的能力。通过建立的HPLC-DAD方法在吉比汤(GB)和发酵的吉比汤(FGB)中检测到六种已知化合物(去水素,天使果糖醇,诺达肯宁,降钙素,福乐菌素和6-姜油醇)和2种不确定的化合物。发酵后6种已知化合物的含量降低。与GB相比,FGB对血管紧张素转化酶活性的抑制作用更强。总之,乳酸杆菌发酵会影响GB中几种化合物的含量,并提高其对血管紧张素转化酶的抑制活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号